Home / Diabetes In Control (page 635)

Diabetes In Control

Oxyntomodulin: Partner to GLP-1?

Oxyntomodulin is a gut peptide released in response to a meal. It is synthesized within specialized enteroendocrine cells called L cells. Oxyntomodulin is released from the intestinal L cells 5-10 minutes after ingestion of food in amounts proportional to calorie intake and levels peak 30 minutes after meals. Oxyntomodulins are …

Read More »

Letter from the Editor #582

The National Committee for Quality Assurance (NCQA) recently held a series of webinars to help clinicians in “Achieving and Outperforming Type 2 Diabetes HEDIS Measures.“ There were a lot of elements that needed to fall into place to make that happen and our Pharm D candidate, Daniel Schultz, listened in …

Read More »

Achieving and Outperforming Type 2 Diabetes HEDIS Measures

A Guide for Managed Care to Provide Clinicians with Tools to Support the Delivery of Consistent High-Quality Care   Reviewed by Daniel Schultz, Doctor of Pharmacy Candidate, University of Florida College of Pharmacy     The first presentation focused on HEDIS, a widely used set of measurements of healthcare performance …

Read More »

Diabetes and Fasting

Red_attention

  People fast for many reasons: blood tests, surgery or other kind of procedure, or for religious reasons. The Diabetes and Fasting handout will guide your patients who need to fast with some tips for those on oral meds or insulin. Download Diabetes and Fasting (pdf) here     For …

Read More »

iGlucose

iGlucose

iGlucose iglucose uses mobile technology to change the way individuals with diabetes manage their condition. By seamlessly communicating data from glucometers to the iglucose diabetes management portal, glucose readings can be shared in real-time with family members, caregivers and health care professionals. iglucose eliminates the burden of keeping logbooks and …

Read More »

Bydureon: Made in the U.S.A for Europeans

Amylin Pharmaceuticals received its first regulatory approval in Europe while approval of the diabetes drug has been delayed at least a year in the US. The approval by the European Commission in June means the 300 employees Amylin has at its manufacturing facility in Ohio will switch gears from making …

Read More »

Obesity Epidemic in US Continues to Spread

Today, the state with the lowest obesity rate would have had the highest rate in 1995. Despite new initiatives aimed at various sectors of society, including schools and restaurants, obesity rates did not drop in one single US state last year, and rose in 16 of them. Twelve states have …

Read More »